K. Salvato

Eribulin induces irreversible mitotic blockade: implications of cell-based pharmacodynamics for in vivo efficacy under intermittent dosing conditions.

Melvin J. Yu, M. Towle, B. Littlefield, 2011, Cancer research.

Characterization of a nonglycosylated single chain urinary plasminogen activator secreted from yeast.

D. Moir, G. Avgerinos, D. Dumais, 1990, The Journal of biological chemistry.

Macrocyclic ketone analogues of halichondrin B.

Lynda Tremblay, Melvin J. Yu, Yoshito Kishi, 2004, Bioorganic & medicinal chemistry letters.

Structurally simplified macrolactone analogues of halichondrin B.

Melvin J. Yu, Y. Wang, M. Towle, 2004, Bioorganic & medicinal chemistry letters.

Fibrin Specific Thrombolysis by Two-Chain Urokinase-Type Plasminogen Activator Cleaved after Arginine 156 by Thrombin

G. Vovis, D. Stump, R. Broeze, 1990, Thrombosis and Haemostasis.

In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B.

Melvin J. Yu, J. J. Chen, D. Quincy, 2001, Cancer research.

In Vitro and In Vivo Anticancer Activities of Synthetic Macrocyclic Ketone Analogues of Halichondrin B 1

Melvin J. Yu, Y. Wang, D. Quincy, 2001 .

Synthesis and evaluation of hapalosin and analogs as MDR-reversing agents.

B. Littlefield, C. Schwartz, Z. Meng, 1999, Bioorganic & medicinal chemistry letters.